» Articles » PMID: 19962840

Managing Hot Flushes in Men After Prostate Cancer--a Systematic Review

Overview
Journal Maturitas
Specialty Geriatrics
Date 2009 Dec 8
PMID 19962840
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Context And Objective: The aim of this study was to describe hot flushes in men with prostate cancer, and their treatment methods.

Method: A systematic review was conducted of the literature indexed between 1966 and 2009 on the MEDLINE, the ISI Web of Knowledge, Cinahl and PsycINFO. Of 252 articles identified, 32 were selected for consideration of their complete texts, of which five were subject to detailed analysis.

Results: Diethylstilbestrol, megestrol acetate and cyproterone acetate have the strongest effect, giving a 75% or larger decrease of the number of hot flushes, but they may have severe or bothersome side-effects. Gabapentin has an uncertain effect. Clonidine is not proven effective for hot flushes. Long-term effects were not evaluated in any of the studies. SSRI/SNRI and acupuncture may have a moderate effect on hot flushes but are not proven in any RCTs.

Conclusion: Hot flushes are common and bothersome symptoms in men with prostate cancer and those taking anti-androgen treatment, and reduce quality of life. Few treatments are available and some are avoided for these patients. Additional prospective treatment studies are needed, with long-term follow-up, in order to evaluate the effects and risks of treatments. Treatments with few or no severe side-effects should be prioritised in future investigations. Experimental studies are also needed to elucidate the mechanism behind hot flushes in men and to suggest routes for the development of new treatments.

Citing Articles

Feasibility of a novel wearable thermal device for management of bothersome hot flashes in patients with prostate cancer.

Peeke P, Billes S, Vetter A, Naghavi N, Le D, Smith M Prostate Cancer Prostatic Dis. 2023; 27(4):736-742.

PMID: 38086919 PMC: 11543604. DOI: 10.1038/s41391-023-00771-2.


Acupuncture versus sham acupuncture and usual care for Antiandrogen-Induced hot fLashes in prostate cancer (AVAIL): study protocol for a randomized clinical trial.

Qin Z, Zang Z, Yu J, Lv J, Li N, Zhang J BMC Complement Med Ther. 2023; 23(1):388.

PMID: 37891531 PMC: 10612187. DOI: 10.1186/s12906-023-04218-y.


A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2).

Crabb S, Morgan A, Hunter M, Stefanopoulou E, Griffiths G, Richardson A Trials. 2023; 24(1):450.

PMID: 37430353 PMC: 10332063. DOI: 10.1186/s13063-023-07325-w.


Effect of Serelys Homme on the Incidence and Severity of Vasomotor Symptoms and Quality-of-Life Impairments in Patients Receiving Hormone Therapy and Radiation for Localized Prostate Cancer: Results of the ESCULAPE Phase 2 Prospective Study.

Belkacemi Y, Coraggio G, Brunel A, Jouhaud A, Ingels A, Joly C Adv Radiat Oncol. 2023; 8(5):101255.

PMID: 37408674 PMC: 10318267. DOI: 10.1016/j.adro.2023.101255.


Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study.

Zimmerman Y, Frydenberg M, van Poppel H, Jeroen A van Moorselaar R, Roos E, Somford D Eur Urol Open Sci. 2022; 45:59-67.

PMID: 36353657 PMC: 9637725. DOI: 10.1016/j.euros.2022.09.006.